Zhiguang Chang

Shenzhen, 518107, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia.

Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia.

Journal: Biomedicines
Published: August 20, 2025

Homoharringtonine and Gilteritinib Synergistically Induce Apoptosis and Suppress Viability in FLT3-ITD-Positive AML Cells.

Homoharringtonine and Gilteritinib Synergistically Induce Apoptosis and Suppress Viability in FLT3-ITD-Positive AML Cells.

Journal: Biomedicines
Published: August 14, 2025

FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia.

FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia.

Journal: Cell reports. Medicine
Published: November 21, 2024

Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.

Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.

Journal: Medical oncology (Northwood, London, England)
Published: September 03, 2024

FLT3 inhibitors induce p53 instability, driven by STAT5/MDM2/p53 competitive interactions in acute myeloid leukemia.

FLT3 inhibitors induce p53 instability, driven by STAT5/MDM2/p53 competitive interactions in acute myeloid leukemia.

Journal: Cancer letters
Published: May 21, 2024

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization.

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization.

Journal: Cell
Published: April 26, 2024

BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3/FLT3LG pathway in bladder cancer.

BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3/FLT3LG pathway in bladder cancer.

Journal: Journal of Cancer
Published: September 12, 2023

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling.

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling.

Journal: Frontiers in oncology
Published: November 05, 2022

SHP2 participates in decidualization by activating ERK to maintain normal nuclear localization of progesterone receptor.

SHP2 participates in decidualization by activating ERK to maintain normal nuclear localization of progesterone receptor.

Journal: Reproduction (Cambridge, England)
Published: October 13, 2022

Resveratrol activates CD8+ T cells through IL-18 bystander activation in lung adenocarcinoma.

Resveratrol activates CD8+ T cells through IL-18 bystander activation in lung adenocarcinoma.

Journal: Frontiers in pharmacology
Published: August 30, 2022

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia.

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia.

Journal: Frontiers in oncology
Published: April 29, 2022

The Metabolic Signature of AML Cells Treated With Homoharringtonine.

The Metabolic Signature of AML Cells Treated With Homoharringtonine.

Journal: Frontiers in oncology
Published: April 29, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026